Filing Details
- Accession Number:
- 0001209191-20-005548
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-30 16:44:04
- Reporting Period:
- 2020-01-24
- Accepted Time:
- 2020-01-30 16:44:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1305253 | Eiger Biopharmaceuticals Inc. | EIGR | Biological Products, (No Disgnostic Substances) (2836) | 361004130 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1686952 | Iii C. Eldon Mayer | C/O Eiger Biopharmaceuticals, Inc. 2155 Park Boulevard Palo Alto CA 94306 | Ex Vp & Chief Commerc. Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-01-24 | 5,000 | $13.52 | 30,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
